02:46 PM EDT, 04/09/2025 (MT Newswires) -- Anixa Biosciences ( ANIX ) shares were up over 10% in recent Wednesday trading after the company said it received a notice of allowance from the US Patent and Trademark Office for its breast cancer vaccine technology.

The patent, licensed exclusively from Cleveland Clinic, broadens the scope of immunogenic compositions in the vaccine. It covers methods of immunizing patients using a protein found in breast tissue and certain breast cancers, Anixa said Wednesday.

Price: 2.63, Change: +0.25, Percent Change: +10.29